Foi realizada busca na base de dados ME-DLINE utilizando o termo MeSH "Acute Kidney Injury", selecionando o subtópico "Epidemiology", e aplicados os filtros de idade e ano de publicação. Também foram realizadas buscas pelos termos "acute renal failure" e "epidemiology" "acute tubular necrosis" e "epidemiology" nos campos título e resumo com os mesmos filtros. Na segunda busca, foram pesquisadas palavras na base de dados LILACS, com os termos "lesão renal aguda", "insuficiência renal aguda" ou "injuria renal aguda" e o filtro de idade. Todos os resumos foram avaliados pelos autores e os artigos considerados mais relevantes, examinados na íntegra. A mortalidade relacionada à Lesão Renal Aguda (LRA) variou entre 3-63% nos estudos incluídos nesta revisão. A etiologia da LRA tem marcantes diferenças regionais, sendo sepse a principal causa em países desenvolvidos. Em países em desenvolvimento, as doenças renais primárias e a hipovolemia ainda configuram causas frequentes de LRA.
IntRoductIon
Acute kidney injury (AKI) is defined as the sudden reduction in renal function that can range from discrete changes in biochemical markers to kidney failure requiring artificial renal support (ARS). It is a severe complication, with high morbidity and mortality in critically-ill patients, and it is often of multifactorial etiology. 1 Until the early 2000s, the absence of standardization for diagnosis, with the existence of more than 30 published definitions for AKI, 2 made it impossible to determine its magnitude, as well as the comparison between the different studies on the subject. The most widely available studies deal primarily with AKI requiring ARS, reporting mortality rates between 11% and 63% in pediatric patients. Children who presented with AKI had longer periods of hospitalization and stayed in a pediatric intensive care unit (PICU), and had a greater need for mechanical ventilation. 5, 6 In addition, children surviving an episode of AKI may progress with chronic kidney disease (up to 60% of children remain with proteinuria, hypertension, and some degree of reduced glomerular filtration rate (GFR)). [7] [8] [9] The need for uniformity in the definition of AKI resulted in the creation of the first standardized definition published in 2004, called RIFLE (Risk, Injury, Failure, Loss, End-stage). Three years afterwards, these criteria were adapted to the pediatric population, giving rise to the pediatric RIFLE (pRIFLE) acronym. 10 Since then, this criterion has undergone two other modifications, the most recent one being the KDIGO (Kidney Disease: Improving Global Outcome) rating system published in 2012. 11 ARS is the most effective treatment for severe AKI in critically-ill patients. The first reports of hemodialysis (HD) use in humans date back to the 1940s, when Kolff et al. described the use of the socalled "artificial kidney" in a 29-year-old woman with chronic glomerulonephritis and uremia. 12 In 1957, the same author described the advances in the equipment developed until then and mentioned the indications for using the artificial kidney, including AKI secondary to shock. The use of HD in children required more time to be implemented due to persistent difficulties, such as the small vessel size in pediatric patients and the need for large volumes to fill the extracorporeal circuit.
14 In 1957, the first report of HD cases in children was published, describing clinical improvement and greater ease in conservative management after its use in 5 five children from 2 to 14 years of age.
14 However, this modality has not proved safe for infants and young children. In this context, Segar et al. described the importance of using peritoneal dialysis in patients under 1 year of age and/ or under 15 kg.
From the earliest reports of AKI to the present day, there has been significant improvement in the techniques and availability of dialysis procedures, as well as dramatic changes in epidemiology, especially regarding the causes of AKI. Primary renal diseases predominated, such as acute glomerulonephritis and hemolytic-uremic syndrome. After the advent of intensive care, sepsis, large surgeries (such as cardiac surgeries) and oncological problems became the most frequent causes, 16, 17 although in developing countries, dehydration is still a relevant cause of AKI. [18] [19] [20] In addition, there have also been technological advances to care for younger children. In 2015, the first hemodialysis in a neonate with AKI was described using a new equipment, specifically developed for this age group.
The aim of this paper is to review the history and to describe the main information about the epidemiology of AKI in pediatric patients.
methods
For this review, we searched the MEDLINE database through the PUBMED portal, using the Mesh term (Medical Subject Headings) "Acute Kidney Injury", selecting the subtopic "Epidemiology". We then applied filters for age (0 to 18 years) and year of publication (last 5 years) were then applied. This search, carried out in April 2017, resulted in 306 papers. We also searched the terms "acute renal failure" and "epidemiology", "acute tubular necrosis" and "epidemiology", in the "title" and "abstract" fields with the same filters (age and year of publication), selecting eight and no paper at all, respectively. The authors evaluated all abstracts, and the papers considered most relevant were examined in their entirety. A second search was carried out in the LILACS database (Latin American and Caribbean Literature in Health Sciences) through the Virtual Health Library portal, using a series of papers on the epidemiology of AKI in Brazil and Latin America, using the following search terms: "acute kidney injury" or "acute renal failure" or "acute renal injury" and the age filter (0 to 18 years). This second search selected 302 papers, which had their summaries examined by the authors. The most relevant papers were evaluated in their entirety; and the selected ones were included in this review. In addition, we carried out direct searches to obtain historical papers on the subject. Papers cited by selected authors and considered relevant were also included in this review.
AKI clAssIfIcAtIon
The first standard definition for AKI was the RIFLE classification, published in 2004. It is an acronym with the initials of the five proposed phases for the AKI classification: risk, injury, failure, loss of function, and end-stage renal disease. This classification was based on two widely available markers for renal function: changes in serum creatinine or glomerular filtration rate and urine output. 2 However, the values considered in its creation contemplated changes in GFR and serum creatinine in adult patients, making it impossible to apply it to the pediatric age group. Within this context, an adaptation of this classification was published in 2007 for the pediatric age group. The P-RIFLE used the estimated reduction in creatinine clearance (CrCl) to measure changes in renal function.
Advances in the studies on the consequences of AKI in critically-ill patients showed that even small increases in serum creatinine caused higher mortality, which led to the development of the Acute Kidney Injury Network (AKIN) for AKI. This new model classified AKI in three stages, according to its severity, with stage 1 defined as an increase of 0.3 mg/dL in serum creatinine in relation to the baseline value. 22 In 2012, the KDIGO classification was established, aiming to unify the three existing classifications to simplify and universalize its use, since it can be used for adult and pediatric patients. This definition, the most current one available in the literature, also takes into account two easily verified characteristics: serum creatinine (or estimated CrCl for patients under 18 years of age) and urine output. 11 Although it is the most current and adequate classification for the pediatric age group, there was still a need for adaptation to the neonatal period, a phase in which renal physiology has particularities. Thus, the KDIGO classification for AKI in the neonatal period was published in 2015, 23 in which stage 2 AKI is when there is reduced urine output for a shorter period; and the absolute value of serum creatinine is greater than or equal to 2.5 mg/ dL is considered stage 3, since it represents a CrCl lower than 10 mL/min/1.73 m 2 in neonates. Another peculiarity is that the baseline creatinine value is defined as the lowest previous value, since creatinine at birth reflects maternal creatinine, and physiologically evolves with falls during the first days of life. 23 The estimated CrCl calculation is done using the Schwartz formula, which considers that CrCl is the result of the multiplication of the patient's height in centimeters by a constant k, divided by serum creatinine in mg/dL. 24, 25 The original formula uses serum creatinine as measured by the Jaffe method and the k-constant varying according to the patient's age range. 24 The most current version of the Schwartz formula uses a single value for the constant k = 0.413, regardless of age group and serum creatinine as measured by the enzymatic method. 25 Estimated creatinine clearance (mL/min/1.73 m 2 ) = k X height (cm)/serum creatinine (mg/dL) Table 1 illustrates the described classifications for AKI.
globAl epidemiology of pediAtRic AKi
Epidemiological data demonstrating the significant financial cost and high morbidity and mortality associated with AKI 26 have been reported in studies on this subject involving pediatric patients in the literature, in recent years. However, these studies are still concentrated in developed countries. Data on AKI characteristics in developing countries remain scarce.
The first large epidemiological study involving a large number of pediatric patients was published in 2010, using the p-RIFLE for AKI diagnosis. An incidence of AKI of 11% has been demonstrated in patients between 31 days and 21 years of age admitted to a PICU in a single US center. A subsequent multicenter study in the same country described the incidence of 3.9 cases/1,000 hospitalizations and there was a need for ARS in 8.8% of the cases. The authors also reported higher mortality in the group requiring ARS (27.1% versus 14.2% p < 0.001). 27 In a prospective assessment involving 226 children aged 0-14 years submitted to RRT at a single center in New Zealand in the period 2001-2006, the authors reported a mortality rate of 11%. 16 New studies have been published using the KDIGO classification as a criterion for the diagnosis of AKI. In a retrospective cohort of 8,260 ICU patients, of whom 974 were diagnosed as having AKI according to the KDIGO criteria, 25.3% mortality was observed in 28 days, being higher in patients who did not recover during the observation period (40.5% x 11.2%, p <0.01). 28 More recently, in a prospective analysis of 4,984 patients between 3 months and 25 years of age, admitted to 32 PICUs in 4 continents, an incidence of 26.9% of AKI at any stage and mortality of 11% in patients with AKI stages 2 or 3 versus 3.4% in patients who did not develop AKI have been reported. 29 In another large epidemiological study carried out in the United States, published in 2014, the authors assessed preterm extreme low-weight and an incidence of AKI of 39.8% was reported, according to the modified KDIGO classification for the neonatal period, as well as a higher mortality and hospitalization time adjusted for the severity of the patient. 30 Available studies on the epidemiology of pediatric AKI in developing countries are mostly observational studies carried out in a single center. An exception is a study involving 388,736 patients under the age of 18 years admitted to 27 Chinese hospitals, which reported an incidence of AKI (AKIN) of 0.32% and a mortality rate of 3.4% in patients who developed AKI at any stage. 18 Studies in Nigeria, India, Thailand and Pakistan showed mortality rates of 41.5%, 50.4% and 30%, respectively. Data on the worldwide epidemiology of AKI are outlined in Table 2 .
epidemiology of pediAtRic AKi in bRAzil
Studies on the epidemiology of AKI in pediatric patients in Brazil are rare. In a retrospective study published in 2008, a global mortality rate of 53.3% was reported in children aged 0 to 12 years in dialysis because of AKI, who underwent peritoneal dialysis, and it was even higher (73.9%) in the neonatal period. 33 Another study, published in 2009, selected 110 children from 1 month to 15 years of age, using serum creatinine values above the normal reference for age and height as inclusion criterion, with a lower overall mortality (33.6%), probably due to the fact that patients less than 1 month old were excluded, and also by the inclusion of patients who had not yet reached the most severe stage of AKI. 34 Studies using pRIFLE for diagnosis and classification of AKI stage in admitted patients in pediatric intensive care units showed that patients who developed AKI during hospitalization had a higher mortality rate and length of hospital stay than patients who maintained normal kidney function. 35, 36 In a more recent study, limited to sepsis-related AKI, a mortality rate of 33.7% was evidenced. The main risk factors for mortality were duration of hospitalization, use of mechanical ventilation, hypoalbuminemia and the need for dialysis. 37 In a prospective epidemiological study in which pRIFLE and KDIGO criteria were used for the diagnosis of AKI, a similar prevalence of AKI was found with both (49.4 and 46.2%, respectively). 36 The observed mortality was 11.4% in patients with AKI diagnosed by pRIFLE and 12.2% in patients diagnosed with AKI according to KDIGO criteria. The first epidemiological studies on AKI, reported primary kidney disease as a common cause. 39 With the advent of intensive therapy and technological advances that have improved care for critically ill patients, the etiologies of AKI have changed dramatically. Currently, multifactorial AKI is a reality because, in the intensive care setting, it is common for the same patient to remain exposed, for example, sepsis, shock and drug nephrotoxicity. In addition, complex cardiac surgeries and chemotherapeutic treatment for neoplasia also evolved and became more widely available, leaving these patients also exposed to the risk of AKI related to this health care.
These etiologic changes are most evident in developed countries, where more studies on AKI are available. In one study, involving patients admitted between 1999 and 2001 to a tertiary center in the United States, ischemia was still reported as the leading cause of AKI (21%), followed by nephrotoxicity (16%) and sepsis (11%). These cases occurred prior to the dissemination of the concepts published by the Surviving Sepsis Campaign, when the onset of early parenteral antibiotic therapy and volume expansion became recommended as an essential therapy for the reduction of related mortality. 41 In developed countries, current data point to sepsis and cardiac surgeries as etiologic agents related to AKI in critically ill patients. 27, 42 When we extend the assessment to hospitalized patients in less complex sectors, the importance of nephrotoxicity as an etiological factor becomes more evident, because although very present in the intensive care setting, its role in the development of AKI is clearly assessed in the absence of other risk factors. Goldstein et al. described the development of AKI in one-third of the low-complexity admissions in patients receiving aminoglycosides for ≥ 3 days or patients who received ≥ 3 nephrotoxic drugs during hospitalization. In neonates, in addition to sepsis, nephrotoxicity and cardiac surgery, perinatal asphyxia also plays an important role as AKI etiology. 44 In developing countries, primary kidney diseases are still important causes of AKI in the pediatric population. In a multicenter study in China, published in 2013, acute glomerulonephritis was the major cause of AKI in the study population, followed by severe dehydration. Table 4 highlights the main etiologies of AKI according to the location and year in which the study was carried out.
futuRe peRspectives
Currently being developed are extensive research in the search for predictive factors of AKI, which goals are to find factors that can predict or detect risks for the occurrence of AKI, allowing the problem to be avoided or attenuated. The widely used renal function marker, creatinine, is restricted due to its late increase in the course of AKI, as well as its susceptibility to changes by non-renal factors, such as gender, age and muscle mass. 45 The new biomarkers appeared as a large promise in this regard. Among them, the most widely studied is neutrophil gelatinase-associated lipocalin (NGAL), which showed good accuracy for the detection of AKI after post-operative insult in cardiac surgeries, sepsis and contrast use. [46] [47] [48] [49] In order to improve the pre-test probability of available biomarkers in 2010, the concept of "renal angina" was developed, which uses features that indicate risk for AKI and early clinical signs of renal damage for its calculation, creating a predictor score of AKI, and which could serve as a screening tool to determine which patients should have their biomarkers dosed. 50, 51 For the calculation of the "Renal Angina Index" (RAI), the authors defined factors that make the child susceptible to AKI, and early clinical signs of AKI (injury). The presence of each characteristic assigns a score, and the score obtained in "risk" is multiplied by the score obtained in "injury", resulting in the "Renal Angina Index". A result greater than or equal to 8 showed prediction for AKI on the 3rd day of admission with an area under the curve of 0.74-0.81. 52 Figure 1 illustrates how the RAI is calculated.
In a recent prospective study, urinary NGAL was incorporated into the RAI and they found that the combined model was able to predict severe and persistent AKI (KDIGO 2 or 3), with an area under the curve of 0.97. 53 Although promising, these observations need to be replicated in other locations. 
conclusIon
The AKI is a serious condition, with a multifactorial etiology in many cases, and with variable mortality, reaching more than 60% in patients undergoing dialysis. From the epidemiological point of view, there is still a significant lack of robust studies on the incidence, prevalence and outcomes of AKI in the pediatric population, notably in developing countries, such as ours. Promising studies aimed at early diagnosis and intervention may prevent its occurrence or mitigate its effects.
